Sun Pharma unveils ₹3,000 crore expansion in Madhya Pradesh, launches Ilumya in India

Market
C
CNBC TV18•03/12/2025
Sun Pharma unveils ₹3,000 crore expansion in Madhya Pradesh, launches Ilumya in India
- •Sun Pharma to invest ₹3,000 crore in a new facility in Madhya Pradesh.
- •Sun Pharma introduces Ilumya in India for treating plaque psoriasis.
- •Ilumya is endorsed globally as an effective treatment for psoriasis.
- •Sun Pharma's India business continues to grow ahead of the market.
- •Sun Pharma shares have gained 8.2% in the last six months but declined 4.5% this year.
Why it matters: Sun Pharma’s ₹3,000 crore investment may boost healthcare manufacturing and jobs in Madhya Pradesh.
✦
Related Articles
Loading more articles...





